Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
6,618,469
-
Share change
-
+1,522,577
-
Total reported value
-
$5,196,175
-
Put/Call ratio
-
27%
-
Price per share
-
$0.78
-
Number of holders
-
43
-
Value change
-
+$1,254,080
-
Number of buys
-
17
-
Number of sells
-
18
Institutional Holders of ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) as of Q3 2020
As of 30 Sep 2020,
ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,618,469 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., Maven Securities LTD, Qube Research & Technologies Ltd, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, NORTHERN TRUST CORP, MORGAN STANLEY, Verdence Capital Advisors LLC, and GSA CAPITAL PARTNERS LLP.
This page lists
43
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.